(Press-News.org) The formation of abnormal strands of protein called amyloid fibrils — associated with two dozen diseases ranging from Alzheimer's to type-2 diabetes — may not be permanent and irreversible as previously thought, scientists are reporting in the Journal of the American Chemical Society. Rather, protein molecules are constantly attaching and detaching from the fibrils, in a recycling process that could be manipulated to yield new treatments for Alzheimer's and other diseases.
In a study that focused on the fibrils associated with Alzheimer's disease (AD), Natàlia Carulla and colleagues explain that scientists once believed that the fibrils themselves caused the memory loss and other symptoms of AD. During the last 10 years, however, suspicion has fallen on some toxic intermediate of the process through which those fibrils form in the brain. This study suggests that fibrils could be a source of those toxic intermediates.
The new study used laboratory techniques to detail molecular recycling within fibrils formed by two proteins, Aβ40 and Aβ42, which is most associated with AD. After monitoring recycling for 40 days, they found that both Aβ40 and Aβ42 molecules recycle within the fibril population, although to different extents. After 40 days, 80 percent of the molecules making up Aβ40 fibrils underwent recycling while only 30 percent did so in Aβ42 fibrils. These observations imply that Aβ42 recycles more slowly.
"In the context of AD, demonstrating that recycling occurs in the fibrils is a step forward but it is also crucial to identify the recycling species involved; whether they are individual Aβ units or small aggregates made of several units," explains Carulla. "It will be important to address if differences in the recycling species within Aβ40 and Aβ42 fibrils are relevant in the development of Alzheimer's disease. We are now working towards this aim. Once we have this information, we will be in a position to devise new therapeutic strategies that can modulate recycling."
###
The authors acknowledge funding from the Fundació La Caixa, Fundació La Marató de TV3, the Generalitat de Catalunya, and the Ministerio de Ciencia e Innovación.
Recycling of Alzheimer's proteins could be key to new treatments
2011-05-26
ELSE PRESS RELEASES FROM THIS DATE:
8 hours of resistance
2011-05-26
Temptations to exceed the speed limit are always plentiful, but only reckless drivers give in to such impulses. Likewise, numerous growth factors always abound in our bodies, but only cancerous cells are quickly "tempted" by these chemicals to divide again and again. Healthy cells, in contrast, divide only after being exposed to growth factors for eight continuous hours. What happens during these eight hours in a healthy cell that resists the call to divide? And even more important, what fails to work properly in the cancerous cell during these same hours? Why do cancerous ...
Listening with 1 atom
2011-05-26
The lab, though it may seem quiet and insulated, can be as full of background noise as a crowded train station when we're trying to catch the announcements. Our brains can filter out the noise and focus on the message up to a certain point, but turning up the volume on the loudspeakers – improving the signal-to-noise ratio – helps as well.
Separating out the signal from the noise – increasing one while reducing the other – is so basic that much of scientific research could not take place without it. One common method, developed by the physicist Robert Dicke at Princeton ...
Immune system release valve
2011-05-26
The molecular machines that defend our body against infection don't huff and puff, but some of them The molecular machines that defend our body against infection don't huff and puff, but some of them apparently operate on the same principle as a steam engine. Weizmann Institute scientists have discovered a mechanism that controls inflammation similarly to a steam-engine valve: Just when the inflammatory mechanism that protects cells against viruses reaches its peak of activity, the molecular "steam-release valve" interferes, restoring this mechanism to its resting state, ...
Sustainable 'bio-derived' jet fuel industry is achievable
2011-05-26
Establishing an economically and environmentally beneficial, 'bio-derived' Australian and New Zealand aviation fuels industry is a viable proposition, according to a report compiled by CSIRO in collaboration with the region's major aviation industry players.The report, Flight Path to Sustainable Aviation, predicts that over the next 20 years a new, sustainable, Australia-New Zealand aviation fuels industry could cut greenhouse gas emissions by 17 per cent, generate more than 12,000 jobs and reduce Australia's reliance on aviation fuel imports by $2 billion per annum.
"This ...
Experts quantify melting glaciers' effect on ocean currents
2011-05-26
A team of scientists from the University of Sheffield and Bangor University have used a computer climate model to study how freshwater entering the oceans at the end of the penultimate Ice Age 140,000 years ago affected the parts of the ocean currents that control climate.
A paper based on the research, co-authored by Professor Grant Bigg, Head of the University of Sheffield's Department of Geography, his PhD student Clare Green, and Dr Mattias Green, a Senior Research fellow at Bangor University's School of Ocean Sciences, is currently featured as an Editor's Highlight ...
Vitamin D increases speed of sperm cells
2011-05-26
Vitamin D is important for optimal reproductive function in both animals and humans. It has long been known that serum vitamin D level is important for reproductive function in various animals, but now researchers from the University of Copenhagen and Copenhagen University Hospital have shown that this relationship can also be demonstrated in humans.
A new study conducted in 300 normal men showed a positive correlation between the percentage of motile sperm and serum vitamin D levels. The study was recently published in the scientific journal Human Reproduction, and showed ...
Quantum sensor tracked in human cells could aid drug discovery
2011-05-26
Groundbreaking research has shown a quantum atom has been tracked inside a living human cell and may lead to improvements in the testing and development of new drugs.
Professor Lloyd Hollenberg from the University of Melbourne's School of Physics who led the research said it is the first time a single atom encased in nanodiamond has been used as a sensor to explore the nanoscale environment inside a living human cell.
"It is exciting to see how the atom experiences the biological environment at the nanoscale," he said.
"This research paves the way towards a new class ...
Enzyme prevents fatal heart condition associated with athletes
2011-05-26
Scientists have discovered an important enzyme molecule that may prevent fatal cardiac disorders associated with cardiac hypertrophy – the leading cause of sudden cardiac death in young athletes.
Cardiac hypertrophy is a disease of the heart muscle where a portion of the tissue is thickened without any obvious cause. It is commonly linked to high blood pressure (hypertension) and excessive exercises and results in a shrinking of the heart chamber and a reduction of its blood-pumping volume.
The condition is also associated with fatal cardiac disorders related to irregular ...
Research says 9/11 produced permanent shift to Republican party among new young US voters
2011-05-26
Research led by the University of Warwick's Centre for Competitive Advantage in the Global Economy has found that not only did the events of 9/11 produce an immediate shift in favour of the Republican party among new young US voters but that shift persisted into later years. The research shows that party strategists should focus on winning over voters when they are young.
The researchers Professor Sharun Mukand, from the University of Warwick, and Professor Ethan Kaplan, from Stockholm University and the University of Maryland, looked at whether the mere act of registering ...
Arrival of direct antiviral agent therapy for hepatitis C sparks debate of who to treat first
2011-05-26
For many patients with the hepatitis C virus (HCV), direct antiviral agents (DAA) offer a potential cure for the disease. The Food and Drug Administration (FDA) has recently approved two new DAAs, telaprevir and boceprevir, and with that clinicians must now decide who should be the first to receive this treatment. Discussion of this timely topic is now available in the June issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
The World Health Organization (WHO) estimates up to 170,000 million ...